3 Geographic Atrophy Clinical Trials in Canton, GA (2026)

Q: How do I join a clinical trial in Canton?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Canton research site will contact you.

Recruiting Geographic Atrophy Studies in Canton

NCT07585266Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

Gastrointestinal Stromal Tumour (GIST) is a soft tissue tumour that develops in the digestive system, most often in the stomach or small intestine. It is caused by changes in certain proteins that cau...

Canton, GAPHASE3800 participantsGlaxoSmithKline

View Study Details

NCT06022029Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose (MED) and/or recommended dose for expan...

Canton, GAPHASE1168 participantsOncoNano Medicine, Inc.

View Study Details

NCT07554521Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

The purpose of this study is to characterize the clinical effects of tislelizumab, including pharmacokinetics (PK), activity, and safety assessments in US racial and ethnic minority patients with huma...

Canton, GAPHASE230 participantsBeOne Medicines

View Study Details

About Geographic Atrophy Clinical Trials in Canton

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 3 geographic atrophy clinical trials recruiting participants in Canton, GA. These studies are seeking a combined 998 participants. Research is being sponsored by GlaxoSmithKline, OncoNano Medicine, Inc., BeOne Medicines. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Canton — FAQ

Are there geographic atrophy clinical trials in Canton?

Yes, there are 3 geographic atrophy clinical trials currently recruiting in Canton, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Canton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Canton research site will contact you about next steps.

Are clinical trials in Canton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Canton studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 3 active trials in Canton are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 15, 2026 from ClinicalTrials.gov